Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy
- 1 April 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9058) , 1063-1065
- https://doi.org/10.1016/s0140-6736(96)09110-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Primary and Secondary Infections by Human Parvovirus B19 following Bone Marrow Transplantation: Characterization by PCR and B-Cell Molecular ImmunologyScandinavian Journal of Infectious Diseases, 1997
- IgG subclass response to human parvovirus B19 infectionClinical and Diagnostic Virology, 1996
- Epitope Type-Specific IgG Responses to Capsid Proteins VP1 and VP2 of Human Parvovirus B19The Journal of Infectious Diseases, 1995
- A STUDY OF THE ROLE OF PARVOVIRUS B19 IN RHEUMATOID ARTHRITISRheumatology, 1995
- Persistence of parvovirus B19 in synovial fluid and bone marrow.Annals of the Rheumatic Diseases, 1995
- Parvovirus B19 and chronic arthritis–causal or casual association?Annals of the Rheumatic Diseases, 1995
- Non-permissiveness of synovial membrane cells to human parvovirus B19 in vitroJournal of General Virology, 1992
- Antigenic parvovims B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression systemVirus Research, 1990
- HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTIONThe Lancet, 1985
- Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period.Journal of Clinical Pathology, 1982